08048035996
Premium Exporter of Genuine RETELEX KIT 18mg Injection from India to Singapore–Orchard |Phoenix Exim

1. General Information

RETELEX KIT 18mg Injection is a prescription thrombolytic medicine containing Reteplase. It is supplied as a sterile injectable preparation and is administered intravenously by trained healthcare professionals. Its principal approved use is the treatment of acute STEMI to help restore blood flow through a blocked coronary artery and reduce the risk of serious outcomes such as heart failure and death.

Because thrombolytic therapy can cause serious bleeding, RETELEX should only be used following appropriate medical assessment in a properly equipped healthcare setting.

2. Product Information

  • Brand: RETELEX KIT
  • Strength: 18mg
  • Active ingredient: Reteplase
  • Therapeutic class: Thrombolytic / fibrinolytic
  • Dosage form: Injectable powder/kit for intravenous administration
  • Primary indication: Acute ST-elevation myocardial infarction (STEMI)
  • Route: Intravenous
  • Manufacturer/brand information: RETELEX is marketed in India under Abbott-related product listings.
  • Storage: Product information should be checked on the specific pack; listings for the Retelex Kit specify refrigerated storage, generally 2–8°C, and protection from freezing.

3. Uses of RETELEX KIT 18mg Injection

The principal use of Reteplase is:

  • Acute ST-elevation myocardial infarction (STEMI)
  • Dissolution of a blood clot blocking blood flow to the heart
  • Restoration of coronary blood flow when thrombolytic treatment is clinically appropriate

The U.S. prescribing information for reteplase specifically identifies acute STEMI as the indication.

4. Benefits of This Medicine

When appropriately selected for thrombolytic treatment, RETELEX may:

  • Help dissolve the clot responsible for coronary artery blockage.
  • Restore blood flow to heart tissue.
  • Reduce the extent of damage caused by prolonged interruption of blood supply.
  • Reduce the risk of heart failure and death associated with acute STEMI.
  • Provide a double-bolus administration regimen, which can facilitate rapid administration in emergency settings.

Important: The benefits depend strongly on correct patient selection and rapid treatment. Primary PCI (angioplasty) may be preferred when it can be performed promptly.

5. Side Effects of RETELEX KIT 18mg Injection

The major safety concern with Reteplase is bleeding. Bleeding can occur at injection or puncture sites and may also occur internally. Serious or life-threatening bleeding, including intracranial bleeding, is possible.

Other possible adverse effects may include:

  • Nausea
  • Vomiting
  • Low blood pressure
  • Injection-site bleeding or bruising
  • Allergic or hypersensitivity reactions
  • Headache or neurological symptoms associated with serious bleeding
  • Reperfusion-related complications

6. Common Side Effects

Commonly reported effects include:

  • Bleeding
  • Injection-site bleeding or bruising
  • Nausea
  • Vomiting
  • Decreased blood pressure

Bleeding is the most important and commonly reported adverse reaction associated with reteplase.

Seek immediate medical attention for severe bleeding, severe headache, confusion, weakness/numbness, difficulty speaking, breathing difficulty, or other sudden neurological symptoms.

7. How to Use RETELEX KIT 18mg Injection

RETELEX must not be self-administered. It is given intravenously by a doctor or trained healthcare professional in an appropriate emergency/cardiac-care setting.

For reteplase, the labeled regimen is two 10-unit intravenous injections, each administered over approximately 2 minutes and given 30 minutes apart. The 18mg vial corresponds to the marketed formulation containing reteplase; healthcare professionals should follow the specific product's approved instructions for reconstitution and administration.

The product should be prepared and administered using appropriate aseptic technique, and the healthcare team should monitor the patient closely.

8. How RETELEX KIT 18mg Works

Reteplase is a recombinant form of tissue plasminogen activator (tPA) and belongs to the thrombolytic class.

It activates plasminogen, which is converted into plasmin. Plasmin breaks down fibrin, an important structural component of blood clots. As the fibrin clot is broken down, blood flow can be restored through the previously blocked vessel.

9. Safety Advice

RETELEX requires careful medical evaluation before administration because of its significant bleeding risk.

Do not use or administer without specialist assessment in situations such as:

  • Active internal bleeding
  • Recent stroke
  • Recent intracranial or spinal surgery
  • Recent serious head trauma
  • Certain intracranial tumors, aneurysms, or arteriovenous malformations
  • Known bleeding disorders
  • Severe uncontrolled hypertension

Additional precautions:

  • Tell the doctor about all medicines being taken, particularly anticoagulants and antiplatelet medicines.
  • Avoid unnecessary invasive procedures or intramuscular injections after thrombolytic treatment.
  • Monitor carefully for abnormal bleeding or bruising.
  • Pregnancy and breastfeeding require individualized medical assessment.
  • Store the product according to the manufacturer's label and maintain the required cold chain where applicable.
  • Do not freeze the product.

10. Frequently Asked Questions (FAQs)

Q1. What is RETELEX KIT 18mg Injection used for?
It contains Reteplase and is primarily indicated for acute ST-elevation myocardial infarction (STEMI) to dissolve the clot and restore blood flow.

Q2. Is RETELEX a blood thinner?
It is more accurately classified as a thrombolytic/fibrinolytic, meaning it actively helps dissolve an existing blood clot rather than simply preventing new clots.

Q3. Can RETELEX be self-injected?
No. It must be administered intravenously by appropriately trained healthcare professionals.

Q4. What is the biggest risk associated with Reteplase?
The major risk is serious bleeding, including potentially life-threatening internal or intracranial bleeding.

Q5. How is reteplase generally administered?
The labeled reteplase regimen consists of two IV doses given 30 minutes apart.

Q6. Does RETELEX require refrigeration?
Product listings specify refrigerated storage, generally 2–8°C. Always follow the storage instructions on the particular manufacturer's package.

Q7. Can RETELEX be used during pregnancy?
Pregnancy requires individual medical assessment. The treating physician should determine whether the potential benefits outweigh the risks.

Q8. What should I do if abnormal bleeding occurs?
Contact the treating medical team immediately. Severe or uncontrolled bleeding is an emergency.

11. Substitute for RETELEX KIT 18mg Injection

A substitute should not be selected solely on the basis of price or strength. The appropriate thrombolytic depends on the patient's condition, clinical guidelines, contraindications, availability, and the treating cardiologist's decision.

A same-composition alternative listed for Retelex 18mg is:

  • Retefast 18mg Injection – Reteplase

Other thrombolytic medicines such as Tenecteplase, Alteplase, or Streptokinase are not automatically interchangeable with Reteplase because their dosing, formulations, indications, and clinical characteristics differ.

12. SEO / B2B Keywords

  • RETELEX KIT 18mg Injection exporter from India
  • RETELEX KIT 18mg Injection supplier India
  • Reteplase 18mg Injection exporter
  • Reteplase Injection pharmaceutical supplier
  • RETELEX KIT 18mg wholesale supplier
  • RETELEX KIT Injection manufacturer India
  • Reteplase thrombolytic injection supplier
  • Reteplase STEMI treatment injection
  • RETELEX 18mg Injection pharmaceutical exporter
  • RETELEX KIT 18mg Injection supplier to USA
  • RETELEX KIT 18mg Injection supplier to UK
  • RETELEX KIT 18mg Injection supplier to Australia
  • RETELEX KIT 18mg Injection supplier to Singapore
  • RETELEX KIT 18mg Injection supplier to Canada
  • RETELEX KIT 18mg Injection supplier to South Korea
  • RETELEX KIT 18mg Injection supplier to UAE
  • Reteplase Injection exporter from Nagpur India
  • Reteplase 18mg pharmaceutical distributor
  • Reteplase emergency cardiac medicine supplier
  • Reteplase thrombolytic medicine exporter
  • RETELEX KIT cardiac medicine supplier
  • RETELEX KIT STEMI medicine exporter
  • Reteplase recombinant tissue plasminogen activator
  • RETELEX KIT 18mg international pharmaceutical supplier
  • Genuine Reteplase 18mg Injection supplier India
Aug 20th, 2026 3:16 PM

Keywords